Vyscoxa Suspension
NDC Package 15370-501-16

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Vyscoxa (celecoxib) suspension is a medication a nonsteroidal anti-inflammatory drug (NSAID), specifically a COX-2 inhibitor, which relieves pain and swelling (inflammation). This formulation utilizes a suspension delivery system. Marketed by Carwin Pharmaceutical Associates, Llc, this product is identified by NDC 15370-501 and is authorized under FDA application NDA211759.

Identification & Billing

NDC Package Code
15370-501-16
Package Description
473 mL in 1 BOTTLE
Product Code
15370-501
11-Digit Billing Format
15370050116
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
473 ML
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Vyscoxa
Non-Proprietary Name
Celecoxib
Substance Name
Celecoxib
Dosage Form
Suspension - A liquid1 dosage form that contains solid particles dispersed in a liquid vehicle.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
CELECOXIB 10 mg/mL
Pharmacologic Class
Usage Information
This medication is a nonsteroidal anti-inflammatory drug (NSAID), specifically a COX-2 inhibitor, which relieves pain and swelling (inflammation). It is used to treat arthritis, acute pain, and menstrual pain and discomfort. The pain and swelling relief provided by this medication helps you perform more of your normal daily activities. If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section. This drug works by blocking the enzyme in your body that makes prostaglandins. Decreasing prostaglandins helps to reduce pain and swelling.

Regulatory & Marketing

Labeler Name
Carwin Pharmaceutical Associates, Llc
Product Type
Human Prescription Drug
FDA Application #
NDA211759
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
07-31-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 15370-501-16 identifies a specific commercial package of 473 ml in 1 bottle of Vyscoxa, a human prescription drug labeled by Carwin Pharmaceutical Associates, Llc. This product is billed per "ML" milliliter and contains an estimated amount of 473 billable units per package. This suspension is formulated for oral use and contains celecoxib as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Carwin Pharmaceutical Associates, Llc on July 31, 2025. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is a nonsteroidal anti-inflammatory drug (NSAID), specifically a COX-2 inhibitor, which relieves pain and swelling (inflammation). It is used to treat arthritis, acute pain, and menstrual pain and discomfort. The pain and swelling relief provided by this medication helps you perform more of your normal daily activities. If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section. This drug works by blocking the enzyme in your body that makes prostaglandins. Decreasing prostaglandins helps to reduce pain and swelling.

How is this Carwin Pharmaceutical Associates, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 15370050116. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 473 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
15370-501-16
11-Digit CMS (5-4-2)
15370-0501-16

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.